Semaglutide treatment effects on anxiety-like behavior and sucrose preference in a rat model of diabetes type 2

Neuroscience Applied 2026 Open access

Read full text
Authors: V. Todorović, K. Jezdić, J. Ivanović, A. Santrač, J. Aranđelović
DOI: 10.1016/j.nsa.2025.106261
Cited by: 0

Abstract

The blockbuster drug semaglutide, a glucagon-like peptide-1 receptor agonist, is widely used for the treatment of diabetes type 2 (T2D) connected with obesity. However, some pharmacovigilance analysis studies on psychiatric adverse events detected potentially associated mood-related changes with semaglutide treatment and suggested further exploration. ...

Fields of Study & Subjects

Diabetes Treatment and Management Regulation of Appetite and Obesity Metabolism Diabetes and Cancer

Publication details

Journal / source
Neuroscience Applied
Volume
5
Pages
106261–106261
Publication date
1 January 2026
Language
EN